Vaccine and Treatment Evaluation Units: Clinical Trial Implementation and Assays to Support a Phase II Influenza Vaccine Trial

Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

Key facts

NIH application ID

10709839

Project number

272201300019I-P00005-27200009-1

Recipient

KAISER FOUNDATION HEALTH PLAN OF WASHINGTON

Principal Investigator

LISA JACKSON

Activity code

N01

Funding institute

NIH

Fiscal year

2022

Award amount

$5,000

Award type

—

Project period

2017-07-28 → 2023-04-30